Global Intelligent Intravenous Infusion Pumps Market Trends 2023: This research elaborates on the industrial trends for topmost industries for the insights on Intelligent Intravenous Infusion Pumps ...
Anti-TNFR2 monoclonal antibody LBL-019 in patients with advanced malignant tumors: A phase I, first-in-human, open-label, multicenter, dose escalation Study. This is an ASCO Meeting Abstract from the ...
International recommendations advise against the use of intravenous rehydration therapy in children with severe acute malnutrition because of the concern about fluid overload, but evidence to support ...
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer Treated in the US Community Setting We ...
Applicants are invited to undertake a 3 year PhD program in partnership with a global leader in blood- and cell-based therapies (Terumo Blood and Cell Technologies Ltd). This opportunity comes with a ...
Researchers completed what is believed to be the first phase I trial of intravenous Helixor M in the U.S. aimed at determining dosing for subsequent clinical trials and to evaluate safety. Mistletoe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback